CFTR and cystic fibrosis: Especially since Johnson and colleagues stated in 1992 that 6–10% of CFTR-corrected cells are sufficient to observe a therapeutic effect in vitro (Johnson et al., 1992), we can speculate that correction of all CF airway cells may not be mandatory to observe the same effect in vivo.